Pertuzumab
Drug timelines are a Plus or Pro feature.
102 regulatory and trial events tracked for Pertuzumab, covering 2012-03-08 to 2026-07-24. Get the full timeline:
Most recent: Clinical Trial Results: Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy [Phase 2]